We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Cytiva Webinar

Label-Free Protein Activity Quantification for Drug Production and QC

Biotherapeutic drugs are complex and can perform their function through interactions with more than one target molecule. During development and quality control, a range of analytical technologies are used to characterize biotherapeutic drugs in terms of their structural integrity and activity. Ligand-binding assays are used for both characterization and quantitation of biotherapeutic drugs, however, current analytical approaches may no longer be sufficient for analyzing emerging drug modalities. 


In this webinar, you will hear how label-free, ligand-binding-based assays can be used throughout the development and manufacturing of drug products for active concentration measurements, target binding, potency (E50) and Fc receptor (FcR) analysis.


Attend this webinar to discover label-free assays for:

  • The quantitation of therapeutic proteins from plasma fractionation
  • Titer analysis of adeno-associated virus 
  • Assessing drug potency based on ligand binding

Speaker
Dr. Michael Murphy
Dr. Michael Murphy
Biacore Application Scientist
Brought to you by
Now Available on Demand!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
Want to invite a colleague?

Click the button below to begin inviting a colleague to this Webinar